Back to home » Top Stories » IAC 2010
XVIII International AIDS Conference
IAC 2010 XVIII International AIDS Conference
Reed Messe Wien
Vienna, Austria
July 18-23, 2010

emailprint

White House Reveals National HIV/AIDS Strategy

July 13, 2010

The White House has released its national strategy to fight HIV/AIDS, which is aimed at reducing the number of new infections and providing high quality care for those living with the virus, The New York Times reports.  

According to the article, the major goals of the strategy are to reduce the rate of new HIV cases by 25 percent over the next five years and to get treatment to 85 percent of newly diagnosed patients within three months. The White House also aims to focus on education, providing stigma-free care and fighting AIDS in developing countries.  

To combat discrimination against people living with HIV, the plan hopes to make HIV awareness programs part of “all educational environments and health and wellness initiatives.” HIV prevention efforts will concentrate on populations most at risk, which include gay and bisexual men and African Americans.  

The strategy will also build on Bush-era policies that fought AIDS in developing countries by setting specific targets and pushing for coordination among government agencies to safeguard against “missteps” and “wasted, duplicated efforts.”  

To read the Times story, click here.  

To download the national HIV/AIDS strategy, click here.  

To download the strategy implementation plan, click here.  

To download the president's memo on the strategy, click here.

Watch video of the complete press conference:


For complete coverage of the strategy, click here.

Search: National HIV/AIDS Strategy, White House

Scroll down to comment on this story.

emailprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 5 (of 5 total)    

peter, new jersey, 2010-07-22 13:05:57
Ryan White Providers and HOPWA in my experience need an overhaul to truly serve the HIV + patient. They lose applications, they promise payment for help with electric, housing subsidy but make you wait over a year, the food vouchers to supermarkets go unpaid. I belive they are sincere in trying, it's their source for funding, town councils voting on paying bills. Obama, if you want to help HIV+ Constituents, lets get easier access to funding $ and make promises of assistance get prompt attention

Jerry, Saint Petersburg, 2010-07-15 14:04:46
At least they are going to have a plan in force, its at least something to look forward to.

J. Combs, Gaithersburg, MD, 2010-07-14 13:10:48
60 pages? I think the biggest conerns are prevention AND equal care/access to medicines and knowledgable Doctors in every state.

Rich Sutton, St. Louis, 2010-07-14 12:29:15
I'm cautiously optimistic. How will it be paid for? And getting the 2000+ people off the APAP waiting lists should be a top priority, and thats not what I heard.

Darren Mitton, Rome GA, 2010-07-14 12:19:46
In other words, more of the same tired rhetoric and propaganda that have cost so many lives.... And very little actual action. I'm sorry, but extremely basic literature and ads do NOT save lives - advances in research those being made available to the public DO.

comments 1 - 5 (of 5 total)    

More from AIDS2010

HIV/AIDS Complications

July 28, 2010
Global Survey: Stigma, Isolation and Discrimination Still Pervasive
Universal HIV Treatment Access No Guarantee of Health for Socially Disadvantaged
July 27, 2010
OM-85 BV: A Bacterial Vaccine Against Respiratory Problems in People with HIV and COPD?
Low Vitamin D Levels Not Associated With HIV Drugs
July 23, 2010
Longer Duration of HIV Infection Might Increase the Risk of Brain Disorders
Nearly 75 Percent of People With HIV Might Have Bone Problems
July 22, 2010
Health Care Providers and People With HIV Not Communicating Effectively
July 21, 2010
Non-AIDS Cancers Occurring at Earlier Age Among People With HIV
Hep C Treatment Effective in HIV Patients With Normal Liver Enzymes
Aging Might Have a Smaller Impact on Immune Function Than Suspected
July 20, 2010
Viramune Boosts Hep C Treatment Efficacy in People With HIV
HIV/HCV Coinfection Further Increases Risk of Bone Fractures
Fewer Malignancies Seen in Those Taking Selzentry

Experimental HIV Drugs

July 23, 2010
More Details of TBR-652’s Antiviral and Anti-Inflammatory Potential Reported
July 22, 2010
ViiV HIV Integrase Inhibitor Performing Well in First-Time Treatment Study
Rilpivirine Has Similar Efficacy and Better Tolerability Than Sustiva
Extended-Release Viramune Has Comparable Safety and Efficacy to Standard Viramune
July 20, 2010
New ViiV Integrase Inhibitor Effective Against Some Isentress-Resistant HIV Strains
July 19, 2010
Argos’s Dendritic Cell Therapy Reduces HIV During Treatment Interruption

HIV Transmission and Prevention

July 29, 2010
Prevention Is Failing to Target MSM When They’re Young Enough
July 26, 2010
HPV Cancer Vaccine Effective for Heterosexual, Gay and Bisexual Men
Study Finds PrEP Is Safe in Gay and Bi Men
July 23, 2010
Circumcision Unlikely to Have Major HIV Prevention Benefit Among Gay Men
July 21, 2010
Microbicide Success Story: What It Means and Where We Go Next
MACS: Childhood Sex Abuse and Victimization Linked to Increased HIV Risk
Full-Scale HIV Treatment and Prevention Could Save Millions of Lives
July 20, 2010
Tenofovir Microbicidal Gel Significantly Cuts HIV Infection Rate
HIV Cases in Young People Are Falling Around the World
July 19, 2010
Preliminary Results Suggest Good Safety and Adherence Profile for PrEP

Starting and Switching Treatment

July 22, 2010
Reyataz/Isentress Combo Spares Norvir and Nukes, But Is Integrase Resistance a Concern?
Possibly No Survival Benefit to Starting HIV Treatment at CD4s of 500 or More
Once-Daily Prezista/Norvir Monotherapy Largely Effective Over 96 Weeks
Abacavir/Lamivudine Equivalent to Tenofovir/Emtricitabine in Canadian Cohort Study
July 19, 2010
Strategies for a Cure Reviewed in Vienna
Kaletra/Isentress Shows Promise as HIV Nuceleoside-Sparing Regimen for First-Line Treatment
Switch From Sustiva to Intelence Reduces Central Nervous System Side Effects
Protease Inhibitor-to-Isentress Switch is Effective, Lipid Friendly

Global HIV/AIDS

July 22, 2010
Health Care Providers and People With HIV Not Communicating Effectively
July 20, 2010
Tenofovir Microbicidal Gel Significantly Cuts HIV Infection Rate
5.2 Million People With HIV in Low- and Middle-Income Countries Now on Treatment
At Least 31 Countries Deporting People Living With HIV
HIV Cases in Young People Are Falling Around the World


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.